超声乳化联合深巩膜切除术治疗小梁-后巩膜微穿孔的疗效。

IF 1.5 Q3 OPHTHALMOLOGY
Journal of Ophthalmic & Vision Research Pub Date : 2025-07-30 eCollection Date: 2025-01-01 DOI:10.18502/jovr.v20.15249
Mahdi Sharifzadeh Kermani, Sana Jalalmanesh, Hesam Fat'hi-Zadeh, Ali Sharifi, Amin Zand
{"title":"超声乳化联合深巩膜切除术治疗小梁-后巩膜微穿孔的疗效。","authors":"Mahdi Sharifzadeh Kermani, Sana Jalalmanesh, Hesam Fat'hi-Zadeh, Ali Sharifi, Amin Zand","doi":"10.18502/jovr.v20.15249","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the impact of inadvertent intraoperative microperforation of the trabeculo-Descemet's membrane (TDM) on postoperative outcomes in cases with cataract and either primary open-angle glaucoma (POAG) or pseudoexfoliative glaucoma (PEXG) during combined phacoemulsification and deep sclerectomy (PDS).</p><p><strong>Methods: </strong>In this prospective case-control study, 73 eyes of 73 patients with cataract and POAG/PEXG who underwent PDS were enrolled. Patients were divided into two groups based on the presence or absence of inadvertent intraoperative TDM microperforation. The primary outcome measures included intraocular pressure (IOP), number of antiglaucoma drugs, and assessment of adverse effects during a six-month follow-up period.</p><p><strong>Results: </strong>Significant decreases in IOP were observed at all follow-up time points (day 7, month 1, and month 6) in both groups compared to baseline (P <math><mo><</mo></math> 0.001). No significant differences in IOP were found between the groups at any time point, except on day 7, while the perforation group exhibited a significantly lower IOP compared to the non-perforation group (11.84 <math><mo>±</mo></math> 4.78 vs 14.03 <math><mo>±</mo></math> 2.50 mmHg, P = 0.017). At month 6, the mean number of antiglaucoma drugs was 0.19 <math><mo>±</mo></math> 0.46 in the perforation group and 0.06 <math><mo>±</mo></math> 0.23 in the non-perforation group, suggesting a significant reduction in both groups compared to baseline (P <math><mo><</mo></math> 0.001) with no statistically significant difference between the two groups (P = 0.124). Hypotony was observed in 3 (8.1%) eyes with perforation, but it resolved without persistent complications in subsequent follow-ups.</p><p><strong>Conclusion: </strong>Inadvertent TDM microperforation during PDS for POAG or PEXG did not impact IOP outcomes compared to non-perforated cases over a six-month period, nor did it increase the incidence of complications.</p>","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"20 ","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320469/pdf/","citationCount":"0","resultStr":"{\"title\":\"Outcomes of Trabeculo-Descemet's Membrane Microperforation During Combined Phacoemulsification and Deep Sclerectomy.\",\"authors\":\"Mahdi Sharifzadeh Kermani, Sana Jalalmanesh, Hesam Fat'hi-Zadeh, Ali Sharifi, Amin Zand\",\"doi\":\"10.18502/jovr.v20.15249\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To evaluate the impact of inadvertent intraoperative microperforation of the trabeculo-Descemet's membrane (TDM) on postoperative outcomes in cases with cataract and either primary open-angle glaucoma (POAG) or pseudoexfoliative glaucoma (PEXG) during combined phacoemulsification and deep sclerectomy (PDS).</p><p><strong>Methods: </strong>In this prospective case-control study, 73 eyes of 73 patients with cataract and POAG/PEXG who underwent PDS were enrolled. Patients were divided into two groups based on the presence or absence of inadvertent intraoperative TDM microperforation. The primary outcome measures included intraocular pressure (IOP), number of antiglaucoma drugs, and assessment of adverse effects during a six-month follow-up period.</p><p><strong>Results: </strong>Significant decreases in IOP were observed at all follow-up time points (day 7, month 1, and month 6) in both groups compared to baseline (P <math><mo><</mo></math> 0.001). No significant differences in IOP were found between the groups at any time point, except on day 7, while the perforation group exhibited a significantly lower IOP compared to the non-perforation group (11.84 <math><mo>±</mo></math> 4.78 vs 14.03 <math><mo>±</mo></math> 2.50 mmHg, P = 0.017). At month 6, the mean number of antiglaucoma drugs was 0.19 <math><mo>±</mo></math> 0.46 in the perforation group and 0.06 <math><mo>±</mo></math> 0.23 in the non-perforation group, suggesting a significant reduction in both groups compared to baseline (P <math><mo><</mo></math> 0.001) with no statistically significant difference between the two groups (P = 0.124). Hypotony was observed in 3 (8.1%) eyes with perforation, but it resolved without persistent complications in subsequent follow-ups.</p><p><strong>Conclusion: </strong>Inadvertent TDM microperforation during PDS for POAG or PEXG did not impact IOP outcomes compared to non-perforated cases over a six-month period, nor did it increase the incidence of complications.</p>\",\"PeriodicalId\":16586,\"journal\":{\"name\":\"Journal of Ophthalmic & Vision Research\",\"volume\":\"20 \",\"pages\":\"\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320469/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Ophthalmic & Vision Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18502/jovr.v20.15249\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmic & Vision Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/jovr.v20.15249","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:探讨白内障合并原发性开角型青光眼(POAG)或假剥脱性青光眼(PEXG)患者在超声乳化联合深度巩膜切除术(PDS)手术中术中不慎发生小叶膜微穿孔(TDM)对术后预后的影响。方法:在这项前瞻性病例对照研究中,73例白内障和POAG/ pegg患者的73只眼接受了PDS。根据术中TDM微穿孔的存在与否将患者分为两组。主要结局指标包括眼内压(IOP)、抗青光眼药物的数量以及6个月随访期间的不良反应评估。结果:与基线相比,两组在所有随访时间点(第7天、第1个月和第6个月)均观察到IOP显著下降(P 0.001)。除第7天外,各组间IOP均无显著差异,而穿孔组IOP明显低于非穿孔组(11.84±4.78 vs 14.03±2.50 mmHg, P = 0.017)。第6个月时,穿孔组平均使用抗青光眼药物0.19±0.46种,未穿孔组平均使用抗青光眼药物0.06±0.23种,两组较基线均显著减少(P 0.001),两组间差异无统计学意义(P = 0.124)。3只(8.1%)眼穿孔后眼压减退,在后续随访中无持续性并发症。结论:在POAG或PEXG的PDS期间,与未穿孔的患者相比,无意的TDM微穿孔在六个月内不会影响IOP结果,也不会增加并发症的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Outcomes of Trabeculo-Descemet's Membrane Microperforation During Combined Phacoemulsification and Deep Sclerectomy.

Purpose: To evaluate the impact of inadvertent intraoperative microperforation of the trabeculo-Descemet's membrane (TDM) on postoperative outcomes in cases with cataract and either primary open-angle glaucoma (POAG) or pseudoexfoliative glaucoma (PEXG) during combined phacoemulsification and deep sclerectomy (PDS).

Methods: In this prospective case-control study, 73 eyes of 73 patients with cataract and POAG/PEXG who underwent PDS were enrolled. Patients were divided into two groups based on the presence or absence of inadvertent intraoperative TDM microperforation. The primary outcome measures included intraocular pressure (IOP), number of antiglaucoma drugs, and assessment of adverse effects during a six-month follow-up period.

Results: Significant decreases in IOP were observed at all follow-up time points (day 7, month 1, and month 6) in both groups compared to baseline (P < 0.001). No significant differences in IOP were found between the groups at any time point, except on day 7, while the perforation group exhibited a significantly lower IOP compared to the non-perforation group (11.84 ± 4.78 vs 14.03 ± 2.50 mmHg, P = 0.017). At month 6, the mean number of antiglaucoma drugs was 0.19 ± 0.46 in the perforation group and 0.06 ± 0.23 in the non-perforation group, suggesting a significant reduction in both groups compared to baseline (P < 0.001) with no statistically significant difference between the two groups (P = 0.124). Hypotony was observed in 3 (8.1%) eyes with perforation, but it resolved without persistent complications in subsequent follow-ups.

Conclusion: Inadvertent TDM microperforation during PDS for POAG or PEXG did not impact IOP outcomes compared to non-perforated cases over a six-month period, nor did it increase the incidence of complications.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
63
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信